glp-1 physiology informs the pharmacotherapy of obesity glp 1 Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy Frontiers | Revisiting food addiction

doi:10.1038/s12276-018-0183-1 131

Slowing digestion : Food will pass slower through your digestive system, keeping you feeling full longer

Fiber: Constipation is common on GLP-1s, and low fiber is often the culprit

GLP-1 infusion in a patient with Cushings disease induced diabetes has indeed demonstrated similar insulinotropic, glucagonostatic and glucose-lowering actions as in patients with type 2 diabetes (31)

& Herrmann, J

For players tracking daily refreshes and lastminute optins, look for concise language in the promo section that details spin activation triggers, any deposit thresholds, and how quickly winnings post to your balance